Safe conversion to cicloral, a generic cylosporine, in both stable and de novo renal transplant recipients.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Volumn 21, Issue 3, 2010, Pages 426-432

  Kahn, Delawir ^a   Muller, Elmi ^b   Pascoe, Michael ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYCLOSPORIN; GENERIC DRUG; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; CHEMISTRY; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; PHARMACOKINETICS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; CHEMISTRY, PHARMACEUTICAL; CREATININE; CYCLOSPORINE; DRUGS, GENERIC; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; THERAPEUTIC EQUIVALENCY; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77955485080     PISSN: 13192442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)